Evolution of S treptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999
- 1 October 2001
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (10) , 959-967
- https://doi.org/10.1097/00006454-200110000-00009
Abstract
Since 1993 the Pan American Health Organization has coordinated a surveillance network with the National Reference Laboratories of Argentina, Brazil, Chile, Colombia, Mexico and Uruguay aimed at monitoring capsular types and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive disease in children <6 years of age. The surveillance system included children 6 years of age and younger with invasive disease caused by S. pneumoniae. The identification, capsular typing and susceptibility to penicillin of the isolates were conducted using a common protocol, based on standard methodologies. By June, 1999, 4,105 invasive pneumococcal isolates had been collected mainly from pneumonia (44.1%) and meningitis (41.1%) cases. Thirteen capsular types accounting for 86.1% of the isolates (14, 6A/6B, 5, 1, 23F, 19F, 18C, 19A, 9V, 7F, 3, 9N and 4) remained the most common types during the surveillance period. Diminished susceptibility to penicillin was detected in 28.6% of the isolates, 17.3% with intermediate and 11.3% with high level resistance. Resistance varied among countries and increased during this period in Argentina, Colombia and Uruguay. Serotypes 14 and 23F accounted for 66.6% of the resistance. These surveillance data clearly demonstrate the potential impact of the introduction of a conjugate vaccine on pneumococcal disease and the need for more judicious use of antibiotics to slow or reverse the development of antimicrobial resistance.Keywords
This publication has 49 references indexed in Scilit:
- Surveillance studies: how can they help the management of infection?Journal of Antimicrobial Chemotherapy, 2000
- Molecular Characterization of Multidrug-Resistant Streptococcus pneumoniae Isolates in KoreaJournal of Clinical Microbiology, 2000
- The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part IIClinical Infectious Diseases, 2000
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000
- Pneumococcal conjugate vaccinesThe Pediatric Infectious Disease Journal, 1999
- Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in IndiaThe Lancet, 1999
- The Pneumococcus at the Millennium: Not Down, Not OutThe Journal of Infectious Diseases, 1999
- Introduction: Acute Respiratory Tract Infections‐The Forgotten PandemicClinical Infectious Diseases, 1999
- Pneumococcal Resistance to β-Lactam Antibiotics: A Global Geographic OverviewMicrobial Drug Resistance, 1995
- Infections Caused by Streptococcus pneumoniae: Clinical Spectrum, Pathogenesis, Immunity, and TreatmentClinical Infectious Diseases, 1992